253 filings
Page 7 of 13
8-K
t7ol3x62 6vmjbw
29 Jul 19
Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
4:11pm
424B5
ji36m bfh7iyp577
25 Jul 19
Prospectus supplement for primary offering
4:42pm
424B5
e0tj1h7x
24 Jul 19
Prospectus supplement for primary offering
4:39pm
8-K
vp2ry
24 Jul 19
Cara Therapeutics Announces Proposed Offering of Common Stock
4:15pm
8-K
dsbja envwx
12 Jul 19
Entry into a Material Definitive Agreement
4:10pm
8-K
sbw0pbk
5 Jun 19
Submission of Matters to a Vote of Security Holders
5:19pm
8-K
zdodj4 ux5heh70e6z
29 May 19
Cara Therapeutics Announces Positive Results From
7:17am
8-K
bmcr1nnwkg2wx
7 May 19
Cara Therapeutics Reports First Quarter 2019 Financial Results
4:10pm
DEFA14A
d3tbqq0tsash2zo2lqhk
24 Apr 19
Additional proxy soliciting materials
4:18pm
EFFECT
v66 cogpgg
5 Apr 19
Notice of effectiveness
12:15am
CORRESP
aqors14hqn
2 Apr 19
Correspondence with SEC
12:00am
UPLOAD
bdg2qm
22 Mar 19
Letter from SEC
12:00am
CT ORDER
d8o4h9pmot5rv 3tay
21 Mar 19
Confidential treatment order
9:54am
S-8
7f9qo9djs0m31 xl
15 Mar 19
Registration of securities for employees
4:34pm
8-K
5c78agobv vs1a08wv
12 Mar 19
Cara Therapeutics Reports Fourth Quarter and Full Year 2018
4:10pm